Friday, November 8, 2024

Merck

Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%

Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. Multinational pharmaceutical giant Merck & Co Inc (NYSE: MRK) has released its Q1 2023 report. The company’s figures show a...
- Advertisement -spot_img

Latest News

Ethereum Analyst Sees Altseason Potential As BTS Is Still Outpacing ETH – Time To Buy Altcoins?

Este artículo también está disponible en español. Ethereum has finally surged after breaking through a critical resistance level that...
- Advertisement -spot_img
Newsletter Signup

Subscribe to our newsletter below and never miss the latest crypto news.